Detailed information for compound 1874289

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 364.787 | Formula: C15H17ClN6O3
  • H donors: 3 H acceptors: 3 LogP: 1.76 Rotable bonds: 8
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCNC(=O)Nc1ccc(cc1Cl)Oc1ncnc(c1C=NOC)N
  • InChi: 1S/C15H17ClN6O3/c1-3-18-15(23)22-12-5-4-9(6-11(12)16)25-14-10(7-21-24-2)13(17)19-8-20-14/h4-8H,3H2,1-2H3,(H2,17,19,20)(H2,18,22,23)
  • InChiKey: BJHCYTJNPVGSBZ-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Toxoplasma gondii apocytochrome b, putative 0.0401 0.2851 1
Loa Loa (eye worm) hypothetical protein 0.0109 0.016 0.025
Trichomonas vaginalis 3-oxo-5-alpha-steroid 4-dehydrogenase, putative 0.0365 0.2517 0.5
Loa Loa (eye worm) hypothetical protein 0.0109 0.016 0.025
Loa Loa (eye worm) hypothetical protein 0.0365 0.2517 0.4559
Wolbachia endosymbiont of Brugia malayi cytochrome b subunit of the bc complex 0.0401 0.2851 0.5
Entamoeba histolytica steroid 5-alpha reductase, putative 0.0365 0.2517 0.5
Loa Loa (eye worm) TK/KIN16 protein kinase 0.0688 0.5493 1
Brugia malayi Immunoglobulin I-set domain containing protein 0.0688 0.5493 1
Trichomonas vaginalis 3-oxo-5-alpha-steroid 4-dehydrogenase, putative 0.0365 0.2517 0.5
Plasmodium falciparum cytochrome b 0.0401 0.2851 0.5
Echinococcus granulosus roundabout 2 0.0109 0.016 0.016
Schistosoma mansoni cytochrome b 0.0401 0.2851 1
Echinococcus granulosus neurotracting:lsamp:neurotrimin:obcam 0.0094 0.0024 0.0024
Plasmodium vivax cytochrome b 0.0401 0.2851 0.5
Trypanosoma cruzi 3-oxo-5-alpha-steroid 4-dehydrogenase, putative 0.0365 0.2517 0.5
Toxoplasma gondii cytochrome b 0.0401 0.2851 1
Leishmania major 3-oxo-5-alpha-steroid 4-dehydrogenase-like protein 0.0365 0.2517 0.5
Trypanosoma cruzi 3-oxo-5-alpha-steroid 4-dehydrogenase, putative 0.0365 0.2517 0.5
Schistosoma mansoni cytochrome b 0.0401 0.2851 1
Onchocerca volvulus Tyrosine kinase homolog 0.0609 0.4762 1
Echinococcus multilocularis roundabout 2 0.0109 0.016 1
Trypanosoma brucei 3-oxo-5-alpha-steroid 4-dehydrogenase-like, putative 0.0365 0.2517 0.5
Echinococcus granulosus cytochrome B 0.0401 0.2851 0.2851
Schistosoma mansoni cell adhesion molecule 0.0094 0.0024 0.0083
Loa Loa (eye worm) cytochrome b 0.0401 0.2851 0.5169
Trichomonas vaginalis 3-oxo-5-alpha-steroid 4-dehydrogenase, putative 0.0365 0.2517 0.5
Mycobacterium ulcerans hypothetical protein 0.0365 0.2517 0.5
Brugia malayi cytochrome b 0.0401 0.2851 0.1122

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.